Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Nov. 7, 2018. David Boudreau.

Executive Summary

David Boudreau, chair of the committee that oversees the Medical Device Single Audit Program (MDSAP), believes "instability" could come to the device industry if international quality systems standard ISO 13485 is retooled right now. See what he wrote to the International Organization for Standardization (ISO) here.

"If changes are implemented to ISO 13485:2016, the Audit Model for MDSAP, which was just recently revised, will have to be completely revised, training of the auditing organizations will need to be conducted, and transition periods will need to be implemented, leading to instability in the MDSAP at a critical time." –David Boudreau, chair, MDSAP Regulatory Authority Council 

Click here for a free trial of Medtech Insight

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT124207

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel